Medical and Pharmaceutical Immutep completely tanks after discontinuing lung cancer drug trial Shares dropped by 88% on Friday the 13th, leaving investors shook Rowan Dunne5 days ago
Medical and Pharmaceutical Immutep starts multinational Phase III lung cancer drug trial at 150 sites It will examine the efficacy of 'eftilagimod alfa' in conjunction with Merck's Keytruda drug and chemo Rowan DunneDecember 12, 2024